Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer (Russian Translation of Cochrane Plain Language Summary)

Abstract

This publication is the Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review: Chuai Y, Rizzuto I, Zhang X, Li Y, Dai G, Otter SJ, Bharathan R, Stewart A, Wang A; Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer; Version published: 04 March 2021; DOI: 10;1002/14651858;CD013348;pub2

Keywords

• angiogenesis inhibitors
• antineoplastic agents
• bevacizumab
• bias
• brachytherapy
• combined modality therapy
• confidence intervals
• gastric fistula
• gastrointestinal hemorrhage
• hypertension
• indazoles
• intestinal fistula
• intestinal perforation
• lapatinib
• neoplasm recurrence local
• progression-free survival
• pyridines
• pyrimidines
• quality of life
• quinazolines
• randomized controlled trials as topic
• sulfonamides
• thromboembolism
• uterine cervical neoplasms
• vascular endothelial growth factor a